Trachelogenin 4′-o-beta-gentiobioside

Description:
Trachelogenin 4′-O-beta-gentiobioside is an analog that has been found in urine samples of Chinese cancer patients. It has shown to be a potent inhibitor of protein kinases, which are enzymes that play a crucial role in the regulation of cell growth and differentiation. Trachelogenin 4′-O-beta-gentiobioside has been shown to inhibit the growth of human tumor cells and induce apoptosis, making it a promising anticancer agent. This compound also exhibits inhibitory activity against mirtazapine, an antidepressant drug that has been associated with cancer development. The potential of trachelogenin 4′-O-beta-gentiobioside as a kinase inhibitor makes it a promising candidate for the development of new anticancer drugs.